© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Experts discuss challenges in sickle cell disease along with the available standard of care and newer FDA-approved agents used in the management of the disease.
March 31st 2021
Wally Smith, MD, and Abdullah Kutlar, MD provide an overview of sickle cell disease and its pathophysiology.
Experts discuss the prevalence and burden of sickle cell disease.
April 7th 2021
Key opinion leaders give insight on the presentation of sickle cell disease, also highlighting acute vs chronic complications of the disease.
Abdullah Kutlar, MD, reviews the guideline recommendations for screening and monitoring of anemia-related sickle cell disease manifestations.
April 14th 2021
Clinicians dive into the impact of sickle cell on quality of life and symptom management
Patrick McGann, MD, MS, reviews the role of hydroxyurea in sickle cell disease, touching on the mechanism of action and expected outcomes.
April 21st 2021
Wally Smith, MD, discusses L-glutamine in the treatment of SCD.
Insight on the screening and monitoring for red blood cell transfusion for the management of sickle cell disease.
April 28th 2021
Experts discuss the considerations, as well as a specific case in patients receiving hemopoietic stem cell transplant (HSCT).
Abdullah Kutlar, MD, reviews the benefits and risks of treating patients with hemopoietic stem cell transplant.